BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7907932)

  • 1. Haloperidol activates tyrosine hydroxylase gene-expression in the rat substantia nigra, pars reticulata.
    Stork O; Hashimoto T; Obata K
    Brain Res; 1994 Jan; 633(1-2):213-22. PubMed ID: 7907932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of tyrosine hydroxylase and its mRNA in the rat substantia nigra pars reticulata by diazepam and picrotoxin.
    Stork O; Hashimoto T; Obata K
    Neurosci Res; 1994 Feb; 19(1):73-80. PubMed ID: 7911985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convergent regulation by ciliary neurotrophic factor and dopamine of tyrosine hydroxylase expression in cultures of rat substantia nigra.
    Magal E; Burnham P; Varon S; Louis JC
    Neuroscience; 1993 Feb; 52(4):867-81. PubMed ID: 8095711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
    Martin LP; Waszczak BL
    Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of GABA transaminase immunoreactivity in the rat substantia nigra pars reticulata.
    Yung KK; Tse YC; Gao ZG; Choi SY; Kwok FS
    Neurosci Lett; 1998 Aug; 253(1):57-60. PubMed ID: 9754804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal changes in the messenger RNA levels of cellular immediate early genes and neurotransmitter/receptor genes in the rat neostriatum and substantia nigra after acute treatment with eticlopride, a dopamine D2 receptor antagonist.
    Sirinathsinghji DJ; Schuligoi R; Heavens RP; Dixon A; Iversen SD; Hill RG
    Neuroscience; 1994 Sep; 62(2):407-23. PubMed ID: 7830888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
    Rots NY; Cools AR; Bérod A; Voorn P; Rostène W; de Kloet ER
    Brain Res; 1996 Feb; 710(1-2):189-96. PubMed ID: 8963658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular anatomy of the development of the human substantia nigra.
    Aubert I; Brana C; Pellevoisin C; Giros B; Caille I; Carles D; Vital C; Bloch B
    J Comp Neurol; 1997 Mar; 379(1):72-87. PubMed ID: 9057113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons.
    Aumann TD; Egan K; Lim J; Boon WC; Bye CR; Chua HK; Baban N; Parish CL; Bobrovskaya L; Dickson P; Horne MK
    J Neurochem; 2011 Feb; 116(4):646-58. PubMed ID: 21166807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta.
    Oertel WH; Tappaz ML; Berod A; Mugnaini E
    Brain Res Bull; 1982; 9(1-6):463-74. PubMed ID: 6129046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease.
    Nicholson LF; Faull RL; Waldvogel HJ; Dragunow M
    Neuroscience; 1995 Jun; 66(3):507-21. PubMed ID: 7644016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra.
    Petri S; Krampfl K; Dengler R; Bufler J; Weindl A; Arzberger T
    J Comp Neurol; 2002 Oct; 452(4):360-6. PubMed ID: 12355418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
    Waszczak BL
    Brain Res; 1990 Apr; 513(1):125-35. PubMed ID: 2140951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine and GABA receptors in cultured substantia nigra neurons: correlation of electrophysiology and immunocytochemistry.
    Kim KM; Nakajima S; Nakajima Y
    Neuroscience; 1997 Jun; 78(3):759-69. PubMed ID: 9153656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subpopulations of mesencephalic dopaminergic neurons express different levels of tyrosine hydroxylase messenger RNA.
    Weiss-Wunder LT; Chesselet MF
    J Comp Neurol; 1991 Jan; 303(3):478-88. PubMed ID: 1672536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein-coupled inward rectifier modulated by dopamine agonists in cultured substantia nigra neurons.
    Kim KM; Nakajima Y; Nakajima S
    Neuroscience; 1995 Dec; 69(4):1145-58. PubMed ID: 8848103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata.
    Hatzipetros T; Raudensky JG; Soghomonian JJ; Yamamoto BK
    J Neurosci; 2007 May; 27(22):5895-902. PubMed ID: 17537960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.